Back

Calidi Biotherapeutics plans $1.2 million registered stock offering

Verifying
  • Calidi Biotherapeutics agreed to sell common shares in a registered direct offering.
  • 1,025,640 shares will be sold at $1.17 each for approximately $1.2 million.
  • The offering is expected to close on or about September 18, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.